Category: diabetes
Babylon Health leads a $30M Series B in US health kiosk operator, Higi
UK-based AI chatbot Babylon Health — which last year raised $550M at a $2BN+ valuation — has led a $30M Series B in US-based Higi, which owns and operates 10,000+ FDA-cleared health kiosks. Higi, which was founded back in 2012 per Crunchbase, has built out a nationwide network of “health…
Read More
LabCorp’s at-home COVID-19 test kit is the first to be authorized by the FDA
LabCorp’s at-home COVID-19 test, which is called ‘Pixel,’ has received the first Emergency Use Authorization (EUA) for such a test missed by the U.S. Food and Drug Administration (FDA). The test is an at-home collection kit, which provides sample collection materials including a nasal swab to the user, who then…
Read More
Using AI, Yes Health cuts costs, improves adherence for weight loss and diabetes treatment
Using a combination of machine learning and computer vision, Yes Health claims it can cut costs and improve adherence for behavioral-based treatments targeting diabetes, obesity and other chronic conditions. Those claims, and the company’s technology-based approach, has netted the company a new $6 million in funding led by Khosla Ventures…
Read More
Livongo stock jumps over 10 percent on revised earnings guidance, pointing to digital health boom
Livongo Health’s stock jumped over ten percent on a day that saw most exchanges tumble after a day of crazy volatility. The digital diagnostics and therapeutics company is benefiting from booming demand for digital health services as remote medicine takes center stage for beleaguered health care providers looking to keep…
Read More
Hims launches group therapy services as first foray into broader mental health initiative
Hims, the startup consumer health brand providing out-of-pocket physician services online, has launched group therapy services through its Hims and Hers brands as part of an initial push into mental health services. The company first began exploring opportunities to expand into the mental health category around eight months ago, and…
Read More
Noom competitor OurPath rebrands as Second Nature, raises $10M Series A
Back in 2018, OurPath emerged as a startup in the U.K. tackling the problem of diabetes. The company helped customers fight the disease, and raised a $3 million round of funding by combining advice from health experts with tracking technology via a smartphone app to help people build healthy habits…
Read More